NL-OMON38286招募中不适用
Pharmacogenetics of drug-induced liver injury - DILI
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 325
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •an ALT > 5 x upper limit of normal (ULN) (or AST when ALT is unavailable)
- •or an ALP > 2 x ULN (especially when associated with 5'-nucleotidase or gamma-glutamyl transpeptidase elevations and when there is no bony cause for rise in ALP)
- •or an ALT > 3 x ULN plus bilirubin > 2 x ULN
排除标准
- •see inclusion criteria
研究者
相似试验
已完成
不适用
To analyze the mechanism of drug-induced liver failure by using iPS cellsPatients with drug-induced liver failureJPRN-UMIN000016354Hokkaido University Hospital24
招募中
不适用
Alterations of Gut Microbiota and Serum Biochemical Markers in DILI PatientsDrug-induced Liver InjuryGut MicrobiotaBiochemical MarkersNCT05465642Wuhan Union Hospital, China90
招募中
不适用
Drug-induced Liver Injury: Itching StudyDrug Induced Liver InjuryPruritusNCT06446609University of Nottingham50
尚未招募
Unknown
Chemotherapy associated liver injury (CALI) in patients treated for gastrointestinal malignanciesCTRI/2024/05/067070MVR Cancer Centre and Research Institute
Unknown
4 期
Cholestatic Drug-induced Liver InjuryHepatitis, ToxicNCT01141322Taipei Veterans General Hospital, Taiwan180